Skip to main content
Internal Medicine logoLink to Internal Medicine
. 2021 May 7;60(20):3225–3229. doi: 10.2169/internalmedicine.7218-21

Gastric Cancer with Multiple Lymph Node Enlargement at the Time of the Sarcoidosis Diagnosis

Yasuyuki Tanaka 1, Yumi Tokubayashi 1, Mitsuya Kikuchi 1, Shigehiko Fujii 1, Toshihiro Kusaka 1, Shinsuke Shibuya 2, Hiroyuki Kokuryu 1
PMCID: PMC8580756  PMID: 33967139

Abstract

An 80-year-old woman was found to have a 40-mm depressed-type gastric cancer. Computed tomography showed multiple lymph node enlargement, including paraaortic lymph nodes. The extent of lymph node enlargement was significant compared with the depth of the primary lesion. We conducted distal gastrectomy, D2 lymph node dissection, and a paraaortic lymph node biopsy. Microscopically, the tumor was diagnosed as mucosal cancer. In the dissected lymph nodes, noncaseating granuloma was found without metastasis of adenocarcinoma. Immunohistochemical staining using Propionibacterium acnes-specific antibodies showed a large number of P. acnes-positive cells in the granulomas. Finally, the tumor was diagnosed as early-stage gastric cancer and sarcoidosis.

Keywords: gastric cancer, sarcoidosis, sarcoid reaction, Propionibacterium acnes, PAB antibody

Introduction

Sarcoidosis is a multisystemic granulomatous disorder characterized by the presence of noncaseating granulomas in the involved organs. This disorder commonly affects young and middle-aged adults who present with bilateral hilar lymphadenopathy, pulmonary infiltration, and ocular and skin lesions (1,2). Furthermore, the liver, spleen, lymph nodes, heart, salivary glands, nervous system, muscles, and other organs may be involved (2).

The diagnosis of sarcoidosis is not standardized but is based on the pathological evidence of noncaseating granuloma and exclusion of alternative causes of granulomatous disease, including Crohn's disease, vasculitis syndrome, sarcoid reaction to malignancy, as well as infectious diseases, such as tuberculosis and syphilis (3,4).

Several cases of concomitant sarcoidosis and malignancy have been reported (5-9). It is often challenging to differentiate lymph node metastasis from other conditions associated with lymph node enlargement, including sarcoidosis (5). Furthermore, sarcoidosis with malignancy is difficult to distinguish from sarcoid reaction with respect to granulomatous diseases, as they are histologically similar (9).

Propionibacterium acnes is an etiologic agent of sarcoidosis (10,11). Immunostaining with P. acnes-specific monoclonal antibodies that react with cell membrane-bound lipoteichoic acid (PAB antibody) has been useful in differentiating sarcoidosis and sarcoid reaction (12).

We herein report a case of early-stage gastric cancer with multiple lymph node enlargement at the time of the sarcoidosis diagnosis that was difficult to stage due to the presence of multiple enlarged lymph nodes mimicking cancer metastasis.

Case Report

An 80-year-old woman was referred to our hospital for the treatment of gastric cancer. Physical and laboratory examinations, which included an assessment of the tumor marker levels, revealed no abnormalities. Esophagogastroduodenoscopy (EGD) showed a 40-mm depressed-type lesion with an ulcer scar located at the anterior wall of the lower gastric body (Fig. 1). A biopsy of a specimen collected from the depressed area revealed poorly differentiated adenocarcinoma. The patient tested positive for anti-Helicobacter pylori immunoglobulin G antibody.

Figure 1.

Figure 1.

Esophagogastroduodenoscopy showed a 40-mm depressed-type lesion with an ulcer scar located at the anterior wall of the lower gastric body (red arrowheads).

Computed tomography (CT) showed enlargement of the bilateral supraclavicular, mediastinal, hilar, retroperitoneal, and paraaortic lymph nodes (Fig. 2a, b). In addition, positron emission tomography (PET) was performed to confirm the staging diagnosis. PET revealed a high fluorodeoxyglucose uptake in multiple lymph nodes, consistent with the lymph node enlargement confirmed on CT (Fig. 2c, d). The extent of lymph node enlargement was significant compared with the depth of the primary lesion. The primary lesion was diagnosed as early gastric cancer on EGD, and there was no regional lymph node enlargement. This result suggested the presence of a concomitant condition other than lymph node metastasis. Accordingly, we strongly suspected that the lymph node enlargement had been caused by systemic diseases, including sarcoidosis, sarcoid reaction to malignancy, infectious diseases, or malignant lymphoma.

Figure 2.

Figure 2.

Computed tomography (CT) and positron emission tomography (PET) images. (a, b) CT showed enlargement of the bilateral supraclavicular, mediastinal, hilar, retroperitoneal, and paraaortic lymph nodes (red arrowheads). (c, d) PET revealed a high fluorodeoxyglucose uptake in multiple lymph nodes, consistent with the lymph node enlargement confirmed on CT.

Additional blood tests and infectious examinations were performed, and the patient's serum calcium (8.7 mg/dL, normal range: 8.2-10.0 mg/dL), lysozyme (6.9 μg/mL, normal range: 5.0-10.2 μg/mL), angiotensin-converting enzyme (16.4 U/L, normal range: 7.0-25.0 U/L), and soluble interleukin 2 receptor (482 U/mL, normal range: 122-496 U/mL) levels were within the normal limits. All infectious examinations showed negative results. Chest radiography, electrocardiogram, and ophthalmoscopy showed no abnormalities. Based on these examinations and PET-CT findings, systemic diseases, including sarcoidosis or sarcoid reaction to malignancy, were suspected. However, distant and regional lymph node metastasis could not be ruled out. A final diagnosis was still not obtained preoperatively.

We conducted distal gastrectomy with B1 reconstruction, D2 lymph node dissection, and a paraaortic lymph node biopsy for the histological diagnosis of multiple lymph node enlargement. A gross examination of the surgically resected specimen showed a 40-mm depressed lesion with an ulcer scar located at the anterior wall of the lower gastric body (Fig. 3). Microscopically, the tumor was diagnosed as poorly differentiated adenocarcinoma and signet ring cell carcinoma in the mucosal layer. In addition, severe fibrosis was evident in the mucosa and submucosal layer (Fig. 4a, b). In the dissected regional and paraaortic lymph nodes, noncaseating granuloma was found without metastasis of adenocarcinoma (Fig. 4c, d). The granuloma was not positive on Ziehl-Neelsen or Grocott staining. Immunohistochemical staining using PAB antibody, which is useful for the diagnosis of sarcoidosis, showed a large number of P. acnes-positive cells in the granulomas (Fig. 4e, f). Finally, the tumor was diagnosed as Type 0-IIc, 40×35 mm, por>sig, pT1a (M), Ly0, V0, pPM0, pDM0, pN0 (0/29), pStage IA gastric cancer (13) and sarcoidosis. One year after surgery, the patient experienced progression without recurrence. In addition, the extent of lymph node enlargement due to sarcoidosis had remained largely unchanged for one year. Currently, the patient has no clinical symptoms of sarcoidosis and is being followed.

Figure 3.

Figure 3.

The macroscopic findings of the resected specimen. The gross appearance showed a 40-mm depressed lesion with an ulcer scar.

Figure 4.

Figure 4.

Histological findings of the resected specimen. (a, b) The tumor was diagnosed as poorly differentiated adenocarcinoma and signet ring cell carcinoma in the mucosal layer. In addition, ulcer scar was observed in the mucosal and submucosal layer. (c, d) In the dissected lymph nodes, noncaseating granuloma was found without metastasis of adenocarcinoma. (e, f) Immunohistochemical staining using Propionibacterium acnes-specific antibodies showed a large number of Propionibacterium acnes-positive cells in the granulomas.

Discussion

We herein report a rare case of sarcoidosis identified during a gastric cancer diagnosis, highlighting the complexity of the diagnostic process. In this case, histological findings, including sampling of the distant lymph node, led to the diagnosis of concomitant gastric cancer and granulomatous disease. Furthermore, it was difficult to differentiate sarcoidosis from sarcoid reaction on imaging and histological examinations. However, the final diagnosis of sarcoidosis was made via PAB antibody staining, which was useful for differentiating the two diseases. In gastric cancer, the use of PAB antibody staining for differentiating sarcoid reaction from sarcoidosis has not previously been reported. Therefore, this case is extremely valuable.

Sarcoidosis is a systemic granulomatous disease of unknown cause that is pathologically characterized by non-caseating granulomas. Furthermore, it is diagnosed by ruling out other systemic granulomatous diseases (3,4). In the present case, it was important to differentiate sarcoidosis from sarcoid reaction.

At present, P. acnes is the only microorganism isolated from sarcoid lesions (14,15). Using quantitative polymerase chain reaction, Ishige et al. discovered that P. acnes resided or proliferated specifically in sarcoid lesions (10,11). To elucidate the pathogenic role of P. acnes, Negi et al. used immunohistochemical methods with novel P. acnes-specific monoclonal antibodies that react with cell membrane-bound lipoteichoic acid (PAB antibody) or ribosome-bound trigger factor protein (TIG antibody) (12). Immunostaining with PAB antibody can detect P. acnes in granulomas in 74-100% of sarcoidosis cases, regardless of the affected organ (14), suggesting an etiological link between sarcoidosis and P. acnes. In addition, the treatment for sarcoidosis is not standardized, but antibiotics for P. acnes can be used. In fact, minocycline and doxycycline have been reported to be effective for sarcoidosis (16,17), suggesting an etiological link between sarcoidosis and P. acnes.

Furthermore, Negi et al. showed that the granuloma was negative for PAB in patients with sarcoid reaction (12). Although a histopathological examination using PAB is not yet widely available, positivity for PAB in this case strongly supported the presence of sarcoidosis rather than sarcoid reaction.

The association between sarcoidosis and malignancy has been reported in several studies. However, the correlation remains controversial (5-9). In gastric cancer cases, cases of sarcoidosis mimicking metastatic cancer have been rarely reported (5,6). In gastrointestinal cancers, it is important to differentiate sarcoid nodules from metastatic lesions preoperatively. However, in patients with sarcoidosis, sarcoid nodules can be found in any organs and lymph nodes, often hampering the differentiation of lesions correlated with metastases and leading to inappropriate treatment of concomitant malignancy (5). In the present case, a preoperative examination revealed multiple lymph node enlargement, which was not in accordance with the primary lesion progression. Therefore, concomitant gastric cancer and systemic disease with multiple lymph node enlargement were instead suspected.

We encountered a rare case of sarcoidosis with multiple lymph node enlargement identified at the time of the early-stage gastric cancer diagnosis. Immunohistochemical staining with PAB might be useful for detecting concomitant sarcoidosis and early-stage gastric cancer. If nonspecific multiple lymph node enlargement is found during the preoperative diagnosis of malignant diseases, it is important to determine the preoperative diagnosis and treatment plan while considering the possibility of concomitant sarcoidosis.

The authors state that they have no Conflict of Interest (COI).

Acknowledgement

We thank Dr. Yoshinobu Eishi (Department of Human Pathology, Tokyo Medical and Dental University Graduate School) for performing the pathological examination associated with this report.

References

  • 1. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 336: 1224-1234, 1997. [DOI] [PubMed] [Google Scholar]
  • 2. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160: 736-755, 1999. [DOI] [PubMed] [Google Scholar]
  • 3. Ebert EC, Kierson M, Hagspiel KD. Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol 103: 3184-3192, 2008. [DOI] [PubMed] [Google Scholar]
  • 4. Fahimi HD, Deren JJ, Gottlieb LS, et al. Isolated granulomatous gastritis: its relationship to disseminated sarcoidosis and regional enteritis. Gastroenterology 45: 161-75, 1963. [PubMed] [Google Scholar]
  • 5. Yang J, Jie N, Wen-DI Z, Yan-Li L, Hong-Yang W, Kang-Sheng G. Sarcoidosis in gastric cancer at the time of diagnosis: a case report. Oncol Lett 9: 1159-1162, 2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Konishi H, Komatsu S, Ichikawa D, et al. Diagnostic problems in gastric cancer patients with sarcoidosis-case report and literature review. Gan To Kagaku Ryoho (Cancer Chemother) 39: 2330-2332, 2012. (in Japanese, Abstract in English). [PubMed] [Google Scholar]
  • 7. Sato Y, Sasano S, Oyama K, Sakuraba M, Onuki T, Nitta S. Lung cancer associated with sarcoidosis. Jpn J Thorac Cardiovasc Surg 51: 21-24, 2003. [DOI] [PubMed] [Google Scholar]
  • 8. Bouros D, Hatzakis K, Labrakis H, Zeibecoglou K. Association of malignancy with diseases causing interstitial pulmonary changes. Chest 121: 1278-1289, 2002. [DOI] [PubMed] [Google Scholar]
  • 9. Blank N, Lorenz H, Anthony D, Witzens-Harig M. Sarcoidosis and the occurrence of malignant diseases. Rheumatol Int 34: 1433-1449, 2014. [DOI] [PubMed] [Google Scholar]
  • 10. Abe C, Iwai K, Mikami R, Hosoda Y. Frequent isolation of Propionibacterium acnes from sarcoidosis lymph nodes. Zentralbl Bakteriol Mikrobiol Hyg A 256: 541-547, 1984. [DOI] [PubMed] [Google Scholar]
  • 11. Ishige I, Usui Y, Takemura T, Eishi Y. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 354: 120-123, 1999. [DOI] [PubMed] [Google Scholar]
  • 12. Negi M, Takemura T, Guzman J, et al. Localization of Propionibacterium acnes in granulomas supports a possible etiologic link between sarcoidosis and the bacterium. Modern Pathology 25: 1284-1297, 2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Japanese Gastric Cancer Assosiation. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14: 101-112, 2011. [DOI] [PubMed] [Google Scholar]
  • 14. Eishi Y, Suga M, Ishige I, et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol 40: 198-204, 2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Ichikawa H, Kataoka M, Hiramatsu J, et al. Quantitative analysis of propionibacterial DNA in bronchoalveolar lavage cells from patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 25: 15-20, 2008. [PubMed] [Google Scholar]
  • 16. Marshall TG, Marshall FE. Sarcoidosis succumbs to antibiotics-implications for autoimmune disease. Autoimmun Rev 3: 295-300, 2004. [DOI] [PubMed] [Google Scholar]
  • 17. Miyazaki E, Ando M, Fukami T, Nureki S, Eishi Y, Kumamoto T. Minocycline for the treatment of sarcoidosis: is the mechanism of action immunomodulating or antimicrobial effect? Clin Rheumatol 27: 1195-1197, 2008. [DOI] [PubMed] [Google Scholar]

Articles from Internal Medicine are provided here courtesy of Japanese Society of Internal Medicine

RESOURCES